- Home
- BNR vs GDTC Comparison
BNR vs GDTC Comparison
Compare BNR & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- GDTC
- Stock Information
- Founded
- BNR 2014
- GDTC 2018
- Country
- BNR China
- GDTC Singapore
- Employees
- BNR 674
- GDTC N/A
- Industry
- BNR Medical Specialities
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- BNR Health Care
- GDTC Health Care
- Exchange
- BNR Nasdaq
- GDTC Nasdaq
- Market Cap
- BNR 38.3M
- GDTC 28.0M
- IPO Year
- BNR 2020
- GDTC 2023
- Fundamental
- Price
- BNR $4.22
- GDTC $2.21
- Analyst Decision
- BNR
- GDTC Buy
- Analyst Count
- BNR 0
- GDTC 1
- Target Price
- BNR N/A
- GDTC $5.00
- AVG Volume (30 Days)
- BNR 29.7K
- GDTC 6.6K
- Earning Date
- BNR 08-21-2025
- GDTC 01-01-0001
- Dividend Yield
- BNR N/A
- GDTC N/A
- EPS Growth
- BNR N/A
- GDTC N/A
- EPS
- BNR N/A
- GDTC N/A
- Revenue
- BNR $72,112,038.00
- GDTC $368,838.00
- Revenue This Year
- BNR $136.32
- GDTC $5.37
- Revenue Next Year
- BNR N/A
- GDTC N/A
- P/E Ratio
- BNR N/A
- GDTC N/A
- Revenue Growth
- BNR 0.53
- GDTC N/A
- 52 Week Low
- BNR $2.18
- GDTC $1.20
- 52 Week High
- BNR $7.90
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- BNR 63.77
- GDTC 49.36
- Support Level
- BNR $3.06
- GDTC $2.09
- Resistance Level
- BNR $3.50
- GDTC $2.35
- Average True Range (ATR)
- BNR 0.21
- GDTC 0.10
- MACD
- BNR 0.05
- GDTC 0.00
- Stochastic Oscillator
- BNR 95.65
- GDTC 50.00
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.